Anti CEACAM1 antibodies and methods of using same
US9261507B2 · kind B2 · utility
1Cited by
19References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 23, 2013 |
| Grant date | Feb 16, 2016 |
| Priority date | — |
| Expiry date | Oct 23, 2033 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/70503
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for diagnosing a cancer characterized by over expression of CEACAM1 using an anti-CEACAM1 antibody or antibody fragment that recognizes CEACAM1 and comprises the same CDR sequences in the same orientation as the CDRs of the antibody produced from a hybridoma cell which has been deposited under ATCC Accession Number PTA-9974.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.